DK0659432T3 - Sukkerbelagt farmaceutisk doseringsenhed - Google Patents

Sukkerbelagt farmaceutisk doseringsenhed

Info

Publication number
DK0659432T3
DK0659432T3 DK94203732.6T DK94203732T DK0659432T3 DK 0659432 T3 DK0659432 T3 DK 0659432T3 DK 94203732 T DK94203732 T DK 94203732T DK 0659432 T3 DK0659432 T3 DK 0659432T3
Authority
DK
Denmark
Prior art keywords
dosing unit
sugar coated
coated pharmaceutical
pharmaceutical dosing
sugar
Prior art date
Application number
DK94203732.6T
Other languages
English (en)
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0659432T3 publication Critical patent/DK0659432T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK94203732.6T 1993-12-23 1994-12-22 Sukkerbelagt farmaceutisk doseringsenhed DK0659432T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (1)

Publication Number Publication Date
DK0659432T3 true DK0659432T3 (da) 1998-02-16

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94203732.6T DK0659432T3 (da) 1993-12-23 1994-12-22 Sukkerbelagt farmaceutisk doseringsenhed

Country Status (16)

Country Link
US (1) US5662936A (da)
EP (1) EP0659432B1 (da)
JP (1) JPH07206681A (da)
KR (1) KR100330560B1 (da)
CN (1) CN1108929A (da)
AT (1) ATE155039T1 (da)
AU (1) AU685538B2 (da)
CA (1) CA2138451C (da)
DE (2) DE69404116T2 (da)
DK (1) DK0659432T3 (da)
ES (1) ES2105501T3 (da)
FI (1) FI116035B (da)
GR (1) GR3024817T3 (da)
NO (1) NO305273B1 (da)
NZ (1) NZ270228A (da)
ZA (1) ZA949929B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
CA2205897A1 (en) * 1994-11-22 1996-05-30 Malcolm Cecil Pike Compositions and methods for contraception and for treatment of benign gynecological disorders
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE69702985T2 (de) * 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
ATE294608T1 (de) 1999-06-05 2005-05-15 Innovata Biomed Ltd Verabreichungsystem für medikamente
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
WO2001027210A1 (en) * 1999-10-11 2001-04-19 Ml Laboratories Plc Medicament delivery device with moisture resistant coating
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
WO2001072285A1 (en) * 2000-03-27 2001-10-04 Kyowa Hakko Kogyo Co., Ltd. Easy-to-take granule
AU2001263506A1 (en) 2000-05-18 2001-11-26 Massachusetts Institute Of Technology Encapsulating a toxic core within a non-toxic region in an oral dosage form
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
JP4705108B2 (ja) * 2004-10-15 2011-06-22 ズートツッカー アクチェンゲゼルシャフト マンハイム／オクセンフルト 改良されたパンコーティング法
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
US20140141147A1 (en) * 2010-12-29 2014-05-22 Nestec S.A. Confectionery product comprising agglomerated oil powder
IN2014DN10980A (da) * 2012-07-03 2015-09-18 Nestec Sa
HK1213932A1 (zh) * 2012-11-22 2016-07-15 赢创罗姆有限公司 由粉末组合物制备颗粒状产品的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
AU8168494A (en) 1995-06-29
KR100330560B1 (ko) 2002-09-05
DE659432T1 (de) 1997-01-30
EP0659432B1 (en) 1997-07-09
FI116035B (fi) 2005-09-15
ES2105501T3 (es) 1997-10-16
NO944991L (no) 1995-06-26
EP0659432A1 (en) 1995-06-28
CA2138451A1 (en) 1995-06-24
NO944991D0 (no) 1994-12-22
DE69404116D1 (de) 1997-08-14
CA2138451C (en) 2007-04-24
ZA949929B (en) 1995-08-23
GR3024817T3 (en) 1998-01-30
KR950016715A (ko) 1995-07-20
NO305273B1 (no) 1999-05-03
CN1108929A (zh) 1995-09-27
FI946043A0 (fi) 1994-12-22
ATE155039T1 (de) 1997-07-15
DE69404116T2 (de) 1997-11-13
JPH07206681A (ja) 1995-08-08
NZ270228A (en) 1995-09-26
FI946043L (fi) 1995-06-24
US5662936A (en) 1997-09-02
AU685538B2 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
NO944991D0 (no) Sukkerbelagt farmasöytisk doseringsenhet
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
NO20003546L (no) Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
AU5587690A (en) Treatment of postmenopausal disorders
IL86089A0 (en) Pharmaceutical compositions containing certain 17-ketosteroids for the prophylaxis and therapy of retroviral infections
IL51297A0 (en) Proline derivatives and related compounds pharmaceutical compositions containing the same and process for the preparation thereof
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
IL65843A (en) Pharmaceutical compositions for the treatment of depression containing 3-aza-bicyclo(3.1.0)hexane derivatives and certain novel compounds of this type
FI930860A7 (fi) Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
AR010857A1 (es) Esteroides sustituidos en la posicion 11, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que loscontienen
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
FI950575A7 (fi) 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
SE9303289D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
IL96814A0 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom,processes for the preparation thereof and pharmaceutical compositions containing them
FR2757512B1 (fr) Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
IT9048540A0 (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.